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Available online 14 November 2015AbstractObjective: The primary objective of this study was to determine the sensitivity, specificity, and predictive values of the Thai Osteoporosis
Foundation (TOPF) and Royal College of Orthopaedic Surgeons of Thailand (RCOST) Clinical Practice Guideline for bone mineral density
(BMD) measurement for the detection of postmenopausal osteoporosis. Its secondary objective was to find better indicators to detect post-
menopausal osteoporosis.
Methods: Postmenopausal women were enrolled in this study between June and December 2014. The clinical risk factors following TOPF and
RCOST Clinical Practice Guideline for BMD measurement were collected. Bone mineral density was measured using dual energy X-ray
absorptiometry.
Results: Four hundred postmenopausal women were enrolled in the study. The mean age of the studied population was 66.16 ± 6.04 years.
Twenty-seven percent of the participants had either osteoporosis of the lumbar spine, femoral neck, or total hip, of which 13.3% had osteoporosis
at the lumbar spine, 21.3% had osteoporosis at the femoral neck, and 2.5% had osteoporosis of the total hip. The sensitivity and specificity for
detecting osteoporosis of the whole TOPF and RCOST guideline were 96.2% and 16.7%, 98.8% and 18.7%, 90.0% and 15.1%, and 97.2% and
19.5% at the lumbar spine, femoral neck, total hip, and any sites, respectively. Multiple logistic regression analysis revealed that only OSTA
1, osteopenia on X-ray and low trauma fracture after age of 40 years were significant clinical risk factors in the detection of postmenopausal
osteoporosis. The Receiver Operating Characteristics (ROC) curve was used to obtain the optimum probability value of osteoporosis at any sites
which revealed that the probability value of 0.2222236 would have a sensitivity of 67% and specificity of 62% as the optimal cut point to detect
osteoporosis. A simple flow diagram of “OSTA 1”, “Osteopenia on X-ray” and “A history of low trauma fracture after age of 40 years” was
developed as a better trade-off guideline for BMD measurement.
Conclusions: This study revealed that the TOPF and RCOST guideline for BMD measurement provided a high true positive rate of disease
detection but with an expense of high false positive rate. The simple flow diagram was proposed as a more appropriate guideline for BMD
measurement in postmenopausal women.
© 2015 The Korean Society of Osteoporosis. Production and hosting by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Osteoporosis is one of the major public health problems
among Thai postmenopausal women [1]. A report on the
prevalence of osteoporosis in Thai women ranging from 40 to
80 years of age found that approximately twenty percent had
osteoporosis of the lumbar spine and fourteen percent had
osteoporosis of the femoral neck [2]. The incidence of
osteoporosis-related fracture is expected to rise in Thailand as
it has already throughout Asia [3]. Osteoporotic fractures can
have a devastating impact on quality of life, leading to chronic
pain, further illness, disability, or even death [4,5]. This il-
lustrates that early diagnosis of osteoporosis is of great
importance, especially since pharmacological treatment has
proved to be cost effective.
In 1994, the World Health Organization has proposed to use
the operational definition of osteoporosis by BMD T-score
criteria. By Dual Energy X-ray Absorptiometer (DXA), oste-
oporosis is defined as a BMD that lies 2.5 standard deviations
or more below the average value for young healthy women (a
T-score of <2.5 SD) [6]. Nevertheless, DXA is costly and is
unavailable in most of the health-care centers in Asia,
including Thailand. It is not cost effective to measure BMD in
all women entering menopause. Clinicians are generally rec-
ommended to look for clinical risk factors in order to deter-
mine which patients are at an increased risk for osteoporosis
which may need further testing with DXA [7]. The appropriate
screening tools should be simple, well-validated, and safe to
the population [8].
There have been lots of attempts worldwide to develop
screening tools to guide physicians in detecting osteoporosis
[9]. In 2010, the Thai Osteoporosis Foundation (TOPF) and
Royal College of Orthopaedic Surgeons of Thailand (RCOST)
developed the Clinical Practice Guideline for BMD mea-
surement [7]. Although the guideline has been available
nationwide for over 4 years, it has never been validated in
clinical practice. As a matter of fact, it is of practical impor-
tance to know which screening tools are appropriate for people
living in each particular region. Accordingly, this study was
primarily intended to determine the sensitivity, specificity, and
predictive values of the TOPF and RCOST guideline for BMD
measurement to detect postmenopausal osteoporosis. It was
secondarily aimed to find better indicators for the condition.
2. Material and methods
Postmenopausal women exhibiting at least 12 months of
amenorrhea were recruited from the Menopause Clinic, King
Chulalongkorn Memorial Hospital from June to December
2014. Women were eligible if they were 40 years and had no
previous BMD measurement. Women were excluded if the
measurement of BMD could not be performed, e.g. inability to
get on the examining table, presence of skeletal structural
abnormalities, osteoarthritis, surgical prosthesis, or lumbar
scoliosis.
This study was approved by the Institutional Review Board
of the Faculty of Medicine, Chulalongkorn University,Bangkok, Thailand. After being informed about the objective
and methodology of the study, all subjects provided written
informed consent before enrollment. The clinical risk factor
history was individually assessed. These included those
appeared in the TOPF and RCOST indications for BMD
measurement which comprised of 1) Female age 65 and older,
2) Early menopause (<45 years), 3) Estrogen deficiency for
more than a year before menopause except for women in
pregnancy and breast-feeding, 4) Long term glucocorticoid
intake (prednisolone 5 mg/day or equal for above 3 months),
5) Parental history of hip fracture, 6) Menopausal women with
a body mass index (BMI) less than 19 kg/m2, 7) Radiographic
osteopenia and/or vertebral deformity as shown by X-ray, 8)
History of low trauma bone fracture, 9) Decrease in height
(>4 cm by hearsay or >2 cm./year by annual measurement),
10) Vulnerable group by OSTA score (OSTA score 1)
[OSTA score: Osteoporosis Self-Assessment Tool for Asian
score ¼ 0.2  [Body weight (kg)  Age (years)] [10].
Weight and height were measured, OSTA score and BMI
were calculated then thoraco-lumbar (TL) spine X-ray was
performed. The BMD was measured utilizing the DXA system
(Hologic Discovery W., Bedford, MA, USA) at the Nuclear
Medicine Division, King Chulalongkorn Memorial Hospital.
The DXA machine was calibrated every morning with the hip
and spine phantoms. The coefficient of variation during the year
in which the study was undertaken was less than 1.5%. The
results given were those for the mean values of L1 e L4 at the
spine, the femoral neck, and the total hip of the non-dominant
side. We complied with the WHO criteria of osteoporosis
(BMD 2.5 SD) to diagnose osteoporosis in this study.
3. Statistical analysis
The sample size was calculated using the sensitivity and
specificity of each of the clinical risk factors, resulting in
the maximum sample size for the calculation. Estimation of
the prevalence of osteoporosis by expert opinion was 25%. In
all, 384 subjects were obtained using a 95% confidence in-
terval and 10% acceptable error rate. Statistical analysis was
performed using the SPSS software for Windows, version
17.0. Patient characteristics were calculated by descriptive
statistics. Sensitivity, specificity and positive and negative
predictive values of both the whole TOPF and RCOST
guideline and each item of clinical risk factors were calculated
by a 2 x 2 table. Multiple Logistic Regression analysis was
used to find the only important clinical risk factors for
detecting any site postmenopausal osteoporosis. The Receiver
Operating Characteristics (ROC) curve was used to find the
optimum probability value for detecting any site post-
menopausal osteoporosis. Finally, we developed the simple
flow diagram for clinical consideration of patient selection for
BMD measurement.
4. Results
A total of 400 postmenopausal women were recruited for
the analysis. The mean age and BMI were 66.16 ± 6.04 years
Table 1
Baseline demographic data.
Characteristics Mean ± SD or median
Age (y) 66.16 ± 6.04
BMI (kg/m2) 24.66 ± 3.98
OSTA score, median (min to max) 2.15 (7.32 to 9.60)
BMI: body mass index (kilogram per meter square).
Table 3
Sensitivity, specificity and predictive values of the TOPF and RCOST
guideline of each particular indication for detecting lumbar spine osteoporosis.
Indicators Sensitivity Specificity PPV NPV
OSTA 1 83.0 35.7 16.5 93.2
Age 65 y 62.3 33.4 12.5 85.3
Osteopenia on X-ray 26.4 72.3 12.7 86.6
Early menopause 26.4 90.2 29.2 88.9
Low trauma fracture after age 40 9.4 99.4 71.4 87.8
BMI <19 kg/m2 9.4 96.3 27.8 87.4
Parental hip fracture 11.3 91.4 16.7 87.1
Height loss 7.5 93.1 14.3 86.8
Estrogen deficiency >1 y 5.7 99.4 60.0 87.3
Steroid use >3 mo 3.8 98.8 33.3 87.1
NPV: negative predictive value, OSTA score: Osteoporosis Self-Assessment
Tool for Asian score ¼ 0.2  [Body weight (kg)  Age (y)], PPV: positive
predictive value, RCOST: Royal College of Orthopaedic Surgeons of
Thailand, TOPF: Thai Osteoporosis Foundation.
Table 4
Sensitivity, specificity, and predictive values of the TOPF and RCOST
guideline of each particular indication for detecting femoral neck osteoporosis.
Indicators Sensitivity Specificity PPV NPV
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respectively. The median OSTA score was 2.15 (range
7.32 to 9.60) as shown in Table 1.
Using WHO criteria, the prevalence of osteoporosis in this
study was 13.3% (53/400), 21.3% (85/400), 2.5% (10/400),
and 27% (108/400) at the lumbar spine, femoral neck, total
hip, and osteoporosis at any site, respectively. There were 39
participants (9.8%) with either wedge or compressive vertebral
fractures without history of significant trauma. All of these
vertebral fractures were asymptomatic. There were 10 partic-
ipants (2.5%) with a history of prolonged use of glucocorticoid
(prednisolone 5 mg/day or equivalent medications for over 3
months), and only 3 women of this group were diagnosed of
osteoporosis. None of the participants in this study had
excessive caffeine intake (>4 cups coffee/day) [11], rheuma-
toid arthritis, chronic anticonvulsant therapy (more than 6
months), or chronic heparin therapy (more than 6 months).
The sensitivity, specificity, and predictive values of the
whole TOPF and RCOST guideline for detecting osteoporosis
are shown in Table 2, and the sensitivity, specificity, and
predictive values of the TOPF guideline for each item are
shown in Tables 3e6 for lumbar spine, femoral neck, total hip,
and any site osteoporosis, respectively.
OSTA 1 and age 65 year were found to have high
sensitivity but low specificity whilst the other indications were
found to have low sensitivity but high specificity (early
menopause, estrogen deficiency more than a year before
menopause, long term glucocorticoid intake, parental history
of hip fracture, body mass index less than 19 kg/m2, radio-
graphic osteopenia by X-ray, history of low trauma bone
fracture, decrease in height (>4 cm or >2 cm/year). We used
multiple logistic regression analysis to identify significant
clinical risk factors and the b (coefficient of variable) of each
particular indication for detecting osteoporosis at any site as
shown in Table 7. Only Osteopenia on X-ray, low trauma
fracture after age of 40, and OSTA 1 were significantly
clinical risk indicators (significant value are less than 0.05).Table 2
Sensitivity, specificity, and predictive values of the whole TOPF and RCOST
guideline for detecting osteoporosis.
Skeletal sites Sensitivity Specificity PPV NPV
Lumbar spine osteoporosis 96.2 16.7 15.0 96.7
Femoral neck osteoporosis 98.8 18.7 24.7 98.3
Total hip osteoporosis 90.0 15.1 2.65 98.3
Osteoporosis at any site 97.2 19.5 30.9 95.0
NPV: negative predictive value, PPV: positive predictive value, RCOST: Royal
College of Orthopaedic Surgeons of Thailand, TOPF: Thai Osteoporosis
Foundation.The logistic regression model estimation can predict the
probability (event) for osteoporosis diagnosis in the patient
according to this equation:
Probability ðeventÞ ¼ e
z
1þ ez
where e ¼ the base of natural logarithms (approx 2.72).
Z ¼ b0 þ b1X1 þ b2X2 þ … þ bpXp
b ¼ the coefficient of the predictor variables
The Receiver Operating Characteristics (ROC) curve was
used to obtain the optimum probability value (for optimum
sensitivity and specificity) for detecting postmenopausal
osteoporosis at any site as shown in Fig. 1.
The relevant ROC curve data (Fig. 2) showed multiple
predicted probability value that produced variation in each
sensitivity and specificity. We considered the probability
value of 0.2222236 (produce sensitivity 67%, specificity
62%) as the optimal statistical cut point for detecting oste-
oporosis at any site (neither for too high sensitivity with low
specificity nor too low sensitivity with high specificity).
Then, we developed a simple flow diagram from theseOSTA 1 77.6 36.2 24.7 85.7
Age 65 y 69.4 34.9 22.3 80.9
Osteopenia on X-ray 41.2 76.2 31.8 82.8
Parental hip fracture 16.5 93.0 38.9 80.5
Early menopause 10.6 87.6 18.8 78.4
Height loss 9.4 93.7 28.6 79.3
Low trauma fracture after age 40 4.7 99.0 57.1 79.4
BMI<19 kg/m2 5.9 95.9 27.8 79.1
Estrogen deficiency >1 y 2.4 99.0 40.0 79.0
Steroid use >3 mo 1.2 98.4 16.7 78.7
NPV: negative predictive value, OSTA: Osteoporosis Self-Assessment Tool for
Asian score ¼ 0.2  [Body weight (kg)  Age (y)], PPV: positive predictive
value, RCOST: Royal College of Orthopaedic Surgeons of Thailand, TOPF:
Thai Osteoporosis Foundation.
Table 5
Sensitivity, specificity, and predictive values of the TOPF and RCOST
guideline of each particular indication for detecting total hip osteoporosis.
Indicators Sensitivity Specificity PPV NPV
Age 65 y 70.0 34.1 2.7 97.8
OSTA 1 40.0 32.6 1.5 95.5
Osteopenia on X-ray 50.0 73.1 4.5 98.3
Steroid use >3 mo 10.0 98.7 16.7 97.7
Early menopause 10.0 87.9 2.1 97.4
BMI<19 kg/m2 10.0 95.6 5.6 97.6
Parental hip fracture 0.0 98.2 0.0 97.5
Estrogen deficiency >1 y 0.0 98.7 0.0 97.5
Low trauma fracture after age 40 0.0 98.2 0.0 97.5
Height loss 0.0 92.8 0.0 97.3
NPV: negative predictive value, OSTA: Osteoporosis Self-Assessment Tool for
Asian score ¼ 0.2  [Body weight (kg)  Age (y)], PPV: positive predictive
value, RCOST: Royal College of Orthopaedic Surgeons of Thailand, TOPF:
Thai Osteoporosis Foundation.
Table 7
Multiple logistic regression analysis of the TOPF and RCOST guideline of
each particular indication for detecting osteoporosis at any site.
Clinical risk indicators Significant value Exponential (beta)
Osteopenia on X-ray 0.026 1.779
Low trauma fracture after age
of 40
0.015 15.176
OSTA 1 0.031 1.929
OSTA: Osteoporosis Self-Assessment Tool for Asian score ¼ 0.2  [Body
weight (kg)  Age (y)], RCOST: Royal College of Orthopaedic Surgeons of
Thailand, TOPF: Thai Osteoporosis Foundation.
106 A. Suwan et al. / Osteoporosis and Sarcopenia 1 (2015) 103e108important indicators to determine BMD measurement for
postmenopausal women (Fig. 3). According to the ROC
curve, BMD measurement will be considered suitable if the
probability >0.22. With this diagram, those who have only
“OSTA 1” or “Osteopenia on X-ray” may not be a good
candidate for BMD measurement (probability of 0.18 and
0.21, respectively). Nevertheless, those who have either “A
history of low trauma fracture after the age of 40 years” or
“OSTA 1” with “Osteopenia on X-ray” are found to be a
good candidate for BMD measurement (probability of 0.71
and 0.47, respectively).
5. Discussion
This study was initiated to validate the TOPF and RCOST
guideline for BMD measurement for the detection of post-
menopausal osteoporosis. The results of this study revealed
that the guideline, as a whole, had high sensitivity or true
positive rate but with the tradeoff of low specificity or high
false positive rate in detecting postmenopausal osteoporosis
(false positive rate ¼ 1  specificity). In other words, a sizable
number of postmenopausal women without osteoporosisTable 6
Sensitivity, specificity, and predictive values of the TOPF and RCOST
guideline of each particular indication for detecting osteoporosis at any site.
Indicators Sensitivity Specificity PPV NPV
OSTA 1 78.7 37.7 31.8 82.7
Age 65 y 69.4 35.3 28.4 75.7
Osteopenia on X-ray 38.0 76.4 37.3 76.9
Early menopause 16.7 89.7 37.5 74.4
Parental hip fracture 13.9 92.8 41.7 74.5
Height loss 10.2 94.2 39.3 73.9
BMI<19 kg/m2 6.5 96.2 38.9 73.6
Low trauma fracture after age
40
5.6 99.7 85.7 74.0
Estrogen deficiency >1 y 2.8 99.3 60.0 73.4
Steroid use >3 mo 1.9 98.6 33.3 73.1
NPV: negative predictive value, OSTA: Osteoporosis Self-Assessment Tool for
Asian score ¼ 0.2  [Body weight (kg)  Age (y)], PPV: positive predictive
value, RCOST: Royal College of Orthopaedic Surgeons of Thailand, TOPF:
Thai Osteoporosis Foundation.would be indicated for BMD measurement. This would cause
patients unnecessary exposure to radiation and healthcare cost
for the measurement.
When considered each particular indication for BMD
measurement, OSTA 1 and age 65 years revealed a high
false positive rate while the other indications gave a high false
negative rate (false negative rate ¼ 1  sensitivity), early
menopause, estrogen deficiency more than a year before
menopause, long term glucocorticoid intake, parental history
of hip fracture, body mass index lower than 19 kg/m2, radio-
graphic osteopenia by X-ray, history of low trauma bone
fracture, decrease in height (>4 cm or >2 cm/year). These
may lead to inappropriate clinical decision for investigation
and therapeutic intervention.
We used multiple logistic regression analysis to identify
significant clinical risk factors in the detection of post-
menopausal osteoporosis and the a^ (coefficient of variable) of
each important clinical risk factor as shown in the Table 7.Fig. 1. Receiver Operating Characteristics (ROC) curve.
Fig. 2. Predicted probability.
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used to find the optimum probability (optimum sensitivity
and specificity) value for detecting postmenopausal osteo-
porosis. Finally, we developed a simple flow diagram for
clinical consideration of BMD measurement that may be a
better tradeoff between the true and false positive rate. With
this diagram, those who have only “OSTA 1” or
“Osteopenia on X-ray” may not be a good candidate forFig. 3. A simple flow diagram to determine BMD measuremenBMD measurement as specified in the RCOST and TOPF
guideline. Nevertheless, those who have either “A history of
low trauma fracture after the age of 40 years” or “OSTA
1” with “Osteopenia on X-ray” are found to be a good
candidate for BMD measurement. The simple flow diagram
may be used as clinical decision algorithm for BMD mea-
surement for the benefits of healthcare cost, reducing inves-
tigational risk and time consume. Cost-effective analysis
should be further considered for the comparison of the cur-
rent TOPF and RCOST guideline as a whole or for each
particular indication with the simple flow diagram developed
in this study.
Though the primary determination of the present study was
to validate the TOPF and RCOST guideline using BMD as the
gold standard, BMD is deemed to be the surrogate outcome of
osteoporotic fracture [12]. It's a matter of fact that a half of
osteoporotic fractures occurred in those without osteoporosis
[13]. It is essential, therefore, for Thailand to have its own
information about the risk of fracture once osteoporosis is
diagnosed.
The participants of this study enrolled from the catchment
area of the Hospital in Bangkok, may not be a good repre-
sentative for the country which comprises of both rural and
urban community. Multicenter study which enrolls people
from different regions may increase the possibility to find
some other risk factors that might not be included in the TOPF
and RCOST guideline. One limitation in this study was the use
of single radiologist for the interpretation of osteopenia and
vertebral deformity. Though it could prevent inter-observer
variations of the radiologic interpretation, the outcome may
be subjective and depended on the radiologist. For the appli-
cability of the simple flow diagram to other ethnicities, there
may be differences in the prevalence of clinical risk factors
used as BMD indicators and the prevalence osteoporosis
which might influence the sensitivity, specificity, PPV, NPV
and the simple flow diagram. Therefore, it would be more
appropriate to validate each ethnicity indication for BMDt for postmenopausal women. BMD: bone mineral density.
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tion of the findings to other ethnicity groups.
In conclusion, this study was intended to validate the
currently used TOPF and RCOST guideline for BMD
measurement in postmenopausal women. The results revealed
a high false positive rate of the whole guideline. A simple flow
diagram was developed from three significant clinical risk
factors identified by the multiple logistic regression. This
may be used as a clinical decision making algorithm
for an appropriate BMD measurement in postmenopausal
osteoporosis.
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